Alnassar Ibrahim, Altinawi Mohamed K, Rekab Mohamad Salem, Alzoubi Hasan, Katbeh Imad
Department of Pediatric Dentistry, Damascus University, Damascus, SYR.
Department of Endodontic, Damascus University, Damascus, SYR.
Cureus. 2022 Nov 22;14(11):e31806. doi: 10.7759/cureus.31806. eCollection 2022 Nov.
Purpose This study aimed to evaluate the effectiveness of both mineral trioxide aggregate (MTA) and bioceramic putty (Well-Root PT) in the pulpotomy of immature permanent molars diagnosed with symptoms of irreversible pulpitis. Materials and methods The study included 30 immature permanent molars with symptoms of irreversible pulpitis in 30 healthy children aged six to eight years. They were randomly distributed into the following two groups according to the material used: group 1 included 15 first permanent molars capped by MTA and group 2 included 15 first permanent molars capped by bioceramic putty. Clinical and radiographical evaluations of the treatment results were made after one week, three months, six months, nine months, and 12 months. Results The success rate in the bioceramic putty group was 93.3% clinically and radiographically after a 12 months follow-up, whereas in the group that underwent MTA treatment no cases of failure were registered with a 100% success rate. No statistical differences were observed between groups (p=0.309). The dentin bridge was formed in 60% of the MTA group and 33.3% of the bioceramic group without any statistically significant differences (p=0.272) after a 12 months follow-up. Conclusion Pulpotomy using biocompatible materials (MTA and bioceramic putty) on immature permanent molars with symptoms of irreversible pulpitis is considered acceptable and effective.
目的 本研究旨在评估三氧化矿物凝聚体（MTA）和生物陶瓷糊剂（Well-Root PT）在诊断为不可逆性牙髓炎症状的年轻恒牙活髓切断术中的有效性。材料与方法 该研究纳入了30名6至8岁健康儿童的30颗有不可逆性牙髓炎症状的年轻恒牙。根据所用材料将它们随机分为以下两组：第1组包括15颗用MTA覆盖的第一恒磨牙，第2组包括15颗用生物陶瓷糊剂覆盖的第一恒磨牙。在1周、3个月、6个月、9个月和12个月后对治疗结果进行临床和影像学评估。结果 生物陶瓷糊剂组在12个月随访后的临床和影像学成功率为93.3%，而接受MTA治疗的组未记录到失败病例，成功率为100%。两组之间未观察到统计学差异（p = 0.309）。12个月随访后，MTA组60%形成了牙本质桥，生物陶瓷组为33.3%，无统计学显著差异（p = 0.272）。结论 对有不可逆性牙髓炎症状的年轻恒牙使用生物相容性材料（MTA和生物陶瓷糊剂）进行活髓切断术被认为是可接受且有效的。
